Announcements A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)   |   Submission to the National Human Rights Commission (NHRC) on behalf of Hub5 (HEaL Institute, APU, Seher-CHSJ, and IAPH) – COPASAH on human rights issues confronted by ASHAS and ANMs during the Covid-19 pandemic | Aug 7, 2020   |   Letter to MMC by FMES, PUCL-MH, FAOW, and MFC urging to restore its order suspending licenses of two doctors accused of abetting the suicide of Dr Payal Tadvi

Colonialism of clinical trials: discerning the positive spin offs

Bashir Mamdani, Meenal Mamdani

DOI: 10.20529/IJME.2005.068


Abstract

It has become increasingly difficult and expensive to test drugs in western countries, with their strict regulations, elabo-rate safety requirements, and small populations, all of which make the recruitment of research subjects difficult. Consequently, many organisations are now outsourcing some of their trials to developing countries such as China, Indonesia, Thailand, and India.

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US